Hers Menopause and HRT Review (2026): Cost, Legitimacy, and What to Know

If you have spent any time scrolling lately, you have probably seen the ads. Hers, the women's health brand from the publicly traded company Hims & Hers Health, has spent the last year pushing hard into menopause and perimenopause care. The pitch is appealing: hormone therapy delivered to your door, no insurance hassle, unlimited messaging with a provider, with oral medication advertised from $79 per month and patches from $134 per month, each with a 12-month plan. If you are in your late forties or early fifties and tired of being told to "just push through" hot flashes and 3 a.m. wake-ups, that pitch lands.

So is Hers worth it? This is an honest, independent look at what Hers actually offers for menopause, what it costs, whether it is legitimate, and the real trade-offs you should understand before you hand over a card number. We are a directory, not a Hers affiliate cheerleader, so you will get the cons alongside the pros. You can also see our full structured breakdown on the Hers provider profile.

What Hers actually offers for menopause

Hers launched a dedicated menopause and perimenopause specialty in 2025, layering it on top of the existing Hims & Hers telehealth machine. The core menopause offering is hormone replacement therapy using estradiol and progesterone: an estradiol pill or patch, a progesterone pill, and estradiol vaginal cream. Its public pages do not say whether the specific products it dispenses are FDA-approved or compounded. Eligible customers complete an online intake, get matched with a licensed clinician, and, if appropriate, receive a prescription shipped to them on a recurring subscription.

A few things stand out as genuinely good. Hers lists an estradiol pill or patch, a progesterone pill, and estradiol vaginal cream as potential parts of its menopause offering, and a licensed provider decides which, if any, suit an individual patient. The subscription also includes online provider messaging and regular check-ins, so follow-up questions about a dose change or a side effect do not cost extra.

If you are still sorting out whether what you are feeling is even menopause, our pages on perimenopause and common menopause symptoms can help you frame the conversation before you start any intake.

The publicly traded scale: why it matters

Hims & Hers Health trades on the NYSE under the ticker HIMS. It reported about $2.35 billion in total revenue for 2025 and about 2.5 million subscribers at December 31, 2025, across all of its brands. Separately, an October 2025 company release projected that the Hers business would pass $1 billion in annual revenue in 2026; that was a projection, not reported Hers revenue. That scale cuts both ways, and it is worth understanding honestly.

On the positive side, scale buys infrastructure: Hers has a polished app and a national pharmacy and fulfillment operation. Its size does not guarantee individual support outcomes, uninterrupted medication supply, or future service continuity.

On the cautious side, a company chasing aggressive revenue targets is, by design, optimized to acquire and retain subscribers. None of this makes Hers illegitimate. It does mean you should read the fine print the way you would with any large subscription business.

Hers menopause cost: what to expect

Here are the ranges as advertised in 2026. Please treat these as a starting point and confirm current pricing on the Hers site before you enroll, because telehealth pricing changes often and varies by plan length and promotion.

• Oral HRT: roughly $79 per month on a 12-month plan.
• Patch-based HRT: roughly $134 per month on a 12-month plan.

Two important caveats. First, those headline numbers come with a 12-month plan, and Hers's public HRT pricing does not say whether that plan is billed monthly or upfront, so confirm the total charge and billing schedule before you enroll. Second, Hers is a cash-pay model. It does not bill your insurance. For some women that is the whole appeal, predictable pricing with no claim denials, but it also means you are paying out of pocket for something that might be partially covered elsewhere.

To put that in context, generic estradiol and progesterone may cost less through a retail pharmacy, depending on the prescription, the pharmacy, your insurance and the current cash price. For non-weight-loss prescriptions filled through its pharmacies, Hers says the subscription price includes the prescription and applicable provider services. Whether that bundle is a bargain depends entirely on your situation. Our guides on HRT cost in 2026 and getting HRT without insurance can help you compare the true all-in number against a local route.

FDA-approved versus compounded: an important distinction

Hers publicly lists estradiol pills or patches, a progesterone pill, and estradiol vaginal cream. Its public pages do not identify the manufacturer or compounding status of the products it may dispense, so ask for the product name and dispensing pharmacy before you start. This matters. The Menopause Society and ACOG have both cautioned that compounded hormone products are not FDA-reviewed for safety, consistency, or dosing accuracy, and they generally recommend FDA-approved options when they fit. If a menopause telehealth brand is steering you toward a custom compounded cream as the default, that is a yellow flag. If you want the full picture, see our explainer on compounded versus FDA-approved HRT.

Hers's separate GLP-1 weight-loss service

Hers also operates a separate weight-loss service that offers GLP-1 treatment to eligible patients. If you are considering it, read carefully, because the regulatory landscape around these drugs has shifted.

GLP-1 medications such as semaglutide and tirzepatide are prescription drugs that require a licensed clinician and eligibility criteria, typically tied to BMI thresholds and related health conditions. There is a critical difference between brand-name, FDA-approved products and compounded versions. During the manufacturer shortages of recent years, large telehealth companies, Hims & Hers among them, sold compounded semaglutide at scale. That has changed. In June 2025, Novo Nordisk publicly ended its collaboration with Hims & Hers, citing concerns about mass compounding and marketing. In March 2026, Hims & Hers announced that it would no longer advertise compounded GLP-1 offerings and said compounded semaglutide could remain available on a limited basis for clinically necessary prescriptions. In 2026, the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulk substances list that large compounders rely on, now that the official shortages have ended; a proposal is not a final decision.

What this means for you as a reader: routine large-scale compounding of these drugs is under growing regulatory pressure, and the legal picture is still moving. We will never point you to gray-market sellers, research-grade peptides, or unlicensed sources, and you should be wary of any platform that frames a compounded GLP-1 as a casual, cheaper "same thing." If you are interested in GLP-1 care, insist on understanding exactly what product you are being prescribed, brand or compounded, and verify its current legal status with your clinician. Start with our pieces on compounded semaglutide in 2026 and how to get Ozempic or Wegovy during menopause. If midlife weight change is your main concern, our page on menopause weight gain is a good grounding read.

The real cons: cancellation terms and depth

This is the part the ads will not show you, and it is the most important section for protecting your trust.

Cancellation and refunds. Hers says a subscription must be canceled at least two days before the applicable renewal processing date. Its terms do not provide refunds for partially used subscription periods, although case-by-case refunds may occur. Hers's help center also says a refund cannot be guaranteed after the pharmacy has processed an order. Check the renewal date shown in your account before making changes.

Breadth versus depth. Hers is a broad platform that does many things, from skincare to mental health to hair loss to weight care to, now, menopause. Its menopause specialty is newer than that of dedicated menopause-first providers. Menopause-focused providers such as Midi Health, Evernow, and Gennev are worth comparing, and some accept insurance. When you compare, check insurance billing, state availability, available dosage forms, clinician qualifications, follow-up structure, and subscription terms directly with each provider. Comparing options side by side using our treatment comparison tool and our 2026 telehealth HRT comparison is worth the twenty minutes.

Who Hers is best for, and who should look elsewhere

Hers is a reasonable fit if you want a convenient, cash-pay path to HRT; you prefer an app and unlimited messaging; and you do not want to use insurance.

You should probably look elsewhere if you want to use insurance, you value a deep menopause specialty over breadth, you are uncomfortable with subscription auto-renewal or Hers's cancellation and refund terms, or you are primarily shopping for GLP-1 weight care and want maximum clarity on the brand-versus-compounded question. In those cases, browse our wider list of telehealth HRT providers before committing.

Whichever way you lean, do not skip the prep. Walk into your intake knowing your symptoms, your history, and your questions. Our free appointment prep tool will help you make that first virtual visit count, with Hers or anyone else.

Bottom line: Hers is a legitimate, convenient menopause option from a major public company, and for the right woman it is a solid choice. Just go in clear-eyed about the cash-pay math, the subscription terms, and the separate, more complicated GLP-1 story.

"Hers sells convenience at a clear starting price, but the subscription fine print, not the medicine, is the part to read before you enroll."

FindMyHRT is an independent directory. Some links to providers are partnerships and we may earn a commission at no extra cost to you. Partners we can earn from may be shown first in some lists, but commission does not affect whether a provider is listed or the facts we report about them. See our Affiliate Disclosure.

Medical Disclaimer: This article is for general educational purposes only and is not medical advice. Hormone therapy, GLP-1 medications, and menopause treatment decisions are individual and should be made with a qualified healthcare provider who knows your full history. Prescription medications require evaluation by a licensed clinician. Always consult your provider before starting or changing any treatment.